Company profile: Padagis
1.1 - Company Overview
Company description
- Provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.
Products and services
- Manufacturing and Distribution: Operates multi-site facilities in the United States and Israel to produce and distribute diverse dosage forms, including controlled substances, supporting generic Rx and OTC portfolios
- Extended Topicals: Delivers prescription-grade products—creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories—covering varied dosage forms for Rx and OTC use
- Paragraph IV Products: Constructs specialty-focused generic items that challenge branded pharmaceutical patents, with manufacturing centered on specialty pharmaceuticals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Padagis
ValitaCell
HQ: Ireland
Website
- Description: Provider of biotechnology that enables faster, cheaper manufacturing of bio-therapeutic drugs, allowing users to select cells with greater regulatory confidence at the earliest stage of the drug development pathway and transforming the cell line development process.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ValitaCell company profile →
Pearl Pathways
HQ: United States
Website
- Description: Provider of life science product development and life-saving devices, diagnostics, and therapeutic products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pearl Pathways company profile →
WCCT Global
HQ: United States
Website
- Description: Provider of clinical trial services, research sites, and trial support for testing the safety and efficacy of new medications and medical devices, including participant recruitment, screening, and follow-up visits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WCCT Global company profile →
Qointa
HQ: Belgium
Website
- Description: Provider of a compliant, validated eHealth platform for device-agnostic patient monitoring and coaching, enabling direct randomization into adaptive clinical trials. Offers digital transformation and software validation solutions, quality and regulatory support (QMS and risk management), medical device software development, and electronic data integrity services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qointa company profile →
Cellipont
HQ: United States
Website
- Description: Provider of cell therapy CDMO services specializing in cell therapy development and small-to-large batch production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellipont company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Padagis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Padagis
2.2 - Growth funds investing in similar companies to Padagis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Padagis
4.2 - Public trading comparable groups for Padagis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →